2-3 Financial Statement Review

Search Synopsis Change Company

Johnson & Johnson (NYS: JNJ) + to Company Analysis List Address: One Johnson & Johnson Plaza,New Brunswick, NJ 08933 United States | Phone: 732 524-0400 | Fax: 732 214-0332 | Company Website: www.jnj.com

Incorporated: November 1887 , NJ, United States IRS Number: 221024240 CUSIP: 47816010 Auditor: PricewaterhouseCoopers LLP Transfer Agent: Computershare Trust Company, N.A., Canton, MA Country: United States

Sector: Pharmaceuticals Industry: Pharmaceutical preparations (SIC 2834) Industry: Pharmaceutical Preparation Manufacturing (NAICS 325412) Number of Employees: 135,100 (Approximate Full-Time as of 12/30/2018) Number of Shareholders: 142,029 (record) (as of 02/15/2019)

Market Cap: 362,540,368,000 Revenue: 81,706,000,000 Net Income: 14,151,000,000 Dividend: 3.75 Dividend Yield: 2.7223 EPS Basic: 5.32 EPS Diluted: 5.25 PE Ratio: 26.2381

Company details Executives Ownership Company financials Equity pricing Reports Filings News Competitors Report builder

Synopsis Highlights History Business Property Subsidiaries Long term debt Capital stock Earnings estimates Business segments

Download Printer Friendly My Mergent Tools

Long Term Debt

Dec. 30, 2018, $30,320,000,000 (including current portion of $2,636,000,000) comprised of:

-- 01 -- $1,139,000,000 4.75% notes, due 2019.

-- 02 -- $494,000,000 1.875% notes, due 2019.

-- 03 -- $300,000,000 0.89% notes, due 2019.

-- 04 -- $699,000,000 1.125% notes, due 2019.

-- 05 -- $51,000,000 3% zero coupon convertible subordinated debentures, due 2020.

-- 06 -- $548,000,000 2.95% debentures, due 2020.

-- 07 -- $499,000,000 1.950% notes, due 2020.

-- 08 -- $449,000,000 3.55% notes, due 2021.

-- 09 -- $349,000,000 2.45% notes, due 2021.

-- 10 -- $998,000,000 1.65% notes, due 2021.

-- 11 -- $1,137,000,000 0.250% notes, due 2022.

-- 12 -- $996,000,000 2.25% notes, due 2022.

-- 13 -- $250,000,000 6.73% debentures, due 2023.

-- 14 -- $805,000,000 3.375% notes, due 2023.

-- 15 -- $498,000,000 2.05% notes, due 2023.

-- 16 -- $851,000,000 0.650% notes, due 2024.

-- 17 -- $627,000,000 5.50% notes, due 2024.

-- 18 -- $748,000,000 2.625% notes, due 2025.

-- 19 -- $1,992,000,000 2.45% notes, due 2026.

-- 20 -- $996,000,000 2.95% notes, due 2027.

-- 21 -- $847,000,000 1.150% notes, due 2028.

-- 22 -- $1,493,000,000 2.90% notes, due 2028.

-- 23 -- $297,000,000 6.95% notes, due 2029.

-- 24 -- $498,000,000 4.95% debentures, due 2033.

-- 25 -- $856,000,000 4.375% notes, due 2033.

-- 26 -- $1,693,000,000 1.650% notes, due 2035.

-- 27 -- $988,000,000 3.55% notes, due 2036.

-- 28 -- $991,000,000 5.95% notes, due 2037.

-- 29 -- $1,486,000,000 3.625% notes, due 2037.

-- 30 -- $696,000,000 5.85% debentures, due 2038.

-- 31 -- $990,000,000 3.40% notes, due 2038.

-- 32 -- $538,000,000 4.50% debentures, due 2040.

-- 33 -- $297,000,000 4.85% notes, due 2041.

-- 34 -- $495,000,000 4.50% notes, due 2043.

-- 35 -- $1,972,000,000 3.70% notes, due 2046.

-- 36 -- $991,000,000 3.75% notes, due 2047.

-- 37 -- $742,000,000 3.500% notes, due 2048.

-- 38 -- $24,000,000 other long-term debt.

Line of Credit: Co. has access to substantial sources of funds at various banks worldwide. In Sept. 2018, Co. secured a 364-day Credit Facility. Total credit available to Co. approximates $10,000,000,000,

Log Out | Administration | Contact Us | Help | Training Calendar Version 2.04

11/29/2019, 8:59:45 PM

Pow ered by Clearbit

Mergent Online - Long Term Debt : Johnson & Johnson https://www-mergentonline-com.proxy-library.ashford.edu/companydetai...

1 of 2 11/29/2019, 8:59 PM

which expires on Sept. 12, 2019. Interest charged on borrowings under the credit line agreements is based on either bids provided by banks, the prime rate or London Interbank Offered Rates plus applicable margins.

For details see below.

Expanded Long Term Debt

Displaying 1-30 (Select CUSIP to view the issue details screen)

CUSIP Issuer Name Issue Description Ticker Coupon Maturity Active

478160AB0 JOHNSON & JOHNSON NT JNJ 8.875 10/15/1990 No

478160AA2 JOHNSON & JOHNSON NT JNJ 9.125 09/15/1992 No

478160AC8 JOHNSON & JOHNSON NT JNJ 8.5 08/15/1995 No

478160AD6 JOHNSON & JOHNSON NT JNJ 8 09/01/1998 No

218525AA1 CORDIS CORPORATION SUB DEB JNJ 12.25 06/15/1999 No

152342AA9 CENTOCOR INCORPORATED SUB NT CONV JNJ 7.25 02/01/2001 No

152342AB7 CENTOCOR INCORPORATED SUB DEB CONV JNJ 6.75 02/01/2001 No

4781609A0 JOHNSON & JOHNSON NT REG S JNJ 6 07/19/2001 No

478160AE4 JOHNSON & JOHNSON NT JNJ 7.375 06/29/2002 No

421969AC0 HEARTPORT INCORPORATED SUB NT CONV JNJ 7.25 05/01/2004 No

421969AA4 HEARTPORT INCORPORATED SUB NT CONV RULE 144A JNJ 7.25 05/01/2004 No

152342AE1 CENTOCOR INCORPORATED SUB DEB CONV JNJ 4.75 02/15/2005 No

022615AD0 ALZA CORPORATION SUB DEB CONV JNJ 5 05/01/2006 No

808905AA1 SCIOS INCORPORATED SUB NT CONV RULE 144A JNJ 5.5 08/15/2009 No

808905AB9 SCIOS INCORPORATED SUB NT CONV JNJ 5.5 08/15/2009 No

478160AK0 JOHNSON & JOHNSON DEB JNJ 6.625 09/01/2009 No

022615AB4 ALZA CORPORATION LIQUID YIELD OPT NT (LYONS) JNJ 0 12/21/2010 No

478160AP9 JOHNSON & JOHNSON GLOBAL NT JNJ 5.15 08/15/2012 No

478160AM6 JOHNSON & JOHNSON GLOBAL DEB JNJ 3.8 05/15/2013 No

022615AC2 ALZA CORPORATION SUB NT ZERO CPN CONV (LYON) JNJ 0 07/14/2014 No

478160AQ7 JOHNSON & JOHNSON GLOBAL NT JNJ 5.55 08/15/2017 No

478160AS3 JOHNSON & JOHNSON EUR$ GLOBAL NT JNJ - 11/06/2019 No

02261WAB5 ALZA CORPORATION SUB DEB ZERO CPN CONV JNJ 0 07/28/2020 Yes

02261WAA7 ALZA CORPORATION SUB DEB ZERO CPN CONV RULE 144A JNJ 0 07/28/2020 No

478160AF1 JOHNSON & JOHNSON DEB JNJ 6.73 11/15/2023 Yes

478160AG9 JOHNSON & JOHNSON DEB JNJ 8.72 11/01/2024 No

478160AR5 JOHNSON & JOHNSON GBP$ GLOBAL NT JNJ - 11/06/2024 Yes

478160AJ3 JOHNSON & JOHNSON DEB JNJ 6.95 09/01/2029 Yes

478160AL8 JOHNSON & JOHNSON GLOBAL DEB JNJ 4.95 05/15/2033 Yes

478160AN4 JOHNSON & JOHNSON GLOBAL NT JNJ 5.95 08/15/2037 Yes

Mergent Online - Long Term Debt : Johnson & Johnson https://www-mergentonline-com.proxy-library.ashford.edu/companydetai...

2 of 2 11/29/2019, 8:59 PM